Filter
375
Filtered Results: 375
Text search:
pfizer
Featured
Recommendations
44
New Publications
120
Language
Document type
No document type
103
Guidelines
82
Studies & Reports
76
Fact sheets
43
Manuals
23
Strategic & Response Plan
18
Resource Platforms
10
Infographics
5
Training Material
4
Situation Updates
4
Videos
4
Online Courses
3
Countries / Regions
Brazil
18
Russia
13
Global
11
Argentina
10
Germany
9
South Africa
9
Ukraine
8
Latin America and the Carribbean
7
Middle East and North Africa
7
Mozambique
6
Chile
5
India
5
Africa
4
West and Central Africa
4
Western and Central Europe
4
Ecuador
4
Colombia
3
China
3
Senegal
3
Paraguay
3
East and Southern Africa
3
Nepal
2
Kenya
2
El Salvador
2
Nigeria
2
Peru
2
Philippines
2
South–East Asia Region
2
Uganda
2
Eastern Europe
2
Indonesia
2
Liberia
2
Timor Leste/ East Timor
1
Ghana
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Syria
1
Iran
1
Congo-Brazzaville
1
Guinea-Bissau
1
Tanzania
1
Congo, Democratic Republic of
1
Eastern Europe and Central Asia
1
United Kingdom
1
Belarus
1
Lebanon
1
Bangladesh
1
Sudan
1
Yemen
1
Angola
1
Chad
1
South Sudan
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
COVID-19
87
Guidelines
33
Studies & Reports
28
Reproductive Health
10
Policies
9
Drugs & Medical Equipment
8
Information, Education and Communication (IEC)
8
Vaccine-preventable Diseases
7
Women & Child Health
7
Dental & Eye Care
4
Paediatrics
4
x MEDBOX Issue Brief & Annual Reports x
4
Pediatrics
4
Capacity Building
4
Statistics
4
Diabetes
3
Maternal & Child Health
3
Humanitarian Crisis
3
Schistosomiasis
2
IEC Material
2
Community Health
2
Surgery & Anaesthesia
2
Gynaecology & Obstetrics
2
Health Systems
2
NTDs & Others
2
Maternal Health
2
HIV & STI
2
Age & Elderly
2
TB
2
Hepatitis
1
Helminthiasis
1
Yaws
1
Child Health
1
Buruli Ulcer
1
Onchocerciasis
1
Lymphaticfilariasis
1
Annual Report MEDBOX
1
Community Health
1
MPOX - Monkeypox
1
Infection Control & Prevention (IPC)
1
Medical Devices & Equipment
1
Policies & Guidelines HIV & TB
1
WASH
1
General Guidelines
1
Protection & Security
1
Women & Child Health
1
Primary Health Care
1
Leishmaniasis
1
Human African Trypanosomiasis
1
Disease Prevention & Control
1
Pharmacy & Technologies
1
Toolboxes
Country specific documents
50
Biontech/Pfizer Comirnaty
23
Communication Material
19
Immunization Guidelines
16
Fair Allocation & Ethical Aspects
15
Access & Strategy
13
COVID-19 Vaccination Information
12
Logistics & Supply
11
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
10
Children/Adolescents Mental Disorders
10
COVID-19 Vaccination
9
Vaccine Hesitancy & Myths
9
Vaxzevria (Astra Zeneca)
9
Booster Doses
8
For General Public & Community
7
Hospital Readiness/Essential Health Services
7
Dashboards & Resource Platforms
7
Global Impact: Socio-economic, health services, TB & HIV
6
mRna Vaccines general
6
Moderna
6
TB/HIV Coinfection
6
General
5
Infection Control General
5
Videos
5
COVAX Initiative
5
Long COVID/ Post-COVID Syndrome
5
Vector-based Vacines General
5
Research & Pipeline
5
Inactivated COVID-19 Vaccines
5
Neurological Disorders
5
Meningitis Prevention & Control
4
Studies
4
General
4
Vaccine Candidates & Research
4
Capacity Building & Resources
4
Alzheimer's Disease & Dementia
4
Substance Use Disorders & Addiction
4
Anxiety Disorders
4
Sustainable Development Goals
3
Cannabis
3
Online Courses & Resources
3
Training, others
3
For Health Worker
3
For Migrants & Refugees
3
Scientific & Research Studies
3
Educational Settings
3
Workplace
3
Physical Distancing
3
SARS-CoV-2 Variants
3
Information Refugees Ukraine
3
COVID-19
3
Education material
3
Statistics & Facts
3
Studies & Reports
3
Clinical Aspects & Diagnostics
3
Drug resistant TB
3
Vision Loss & Blindness
3
Global Health Institutions and Stakeholders
3
Background PTSD in children
2
Treatment & Prevention
2
Country specific
2
Children & Adolescents
2
Anamnesis / Screening
2
Stroke
2
Social Worker
2
Health Personnel
2
COVID-19 Information
2
For Parents & Children
2
For Pregnant Women
2
Faith-based Organizations
2
Appeals and Response Plans
2
Information for the Public
2
Paediatrics
2
Mythbusters/Misinformation
2
Tips & Best Practice Examples
2
Vaccination & Strategy
2
Studies & Reports
2
Essential Medicines
2
Prices and Patents
2
Situation Reports & Updates
2
General Information & Methodology
2
Health Financing Toolbox
2
Women
2
General
2
Research & Access
2
Refugees & Migrants
2
Depression
2
Meningitis & Encephalitis
2
Volunteers
2
Africa
1
Rapid Response
1
Clinical Guidelines
1
Policies & Strategies
1
Assessment & Studies
1
ART Drug Resistance
1
Local Action
1
General Reports
1
Agriculture & Veterinary
1
IEC Materials General
1
IPC
1
Vaccines & Immunization
1
Prevention & Control
1
Vaccination
1
Adults
1
Pediatrics
1
Information for Refugees & Migrants
1
Schizophrenia
1
General Mental Health Guidelines
1
Public Health
1
Orphans & vulnerable children
1
Stigma & Discrimination
1
General Studies & Reports
1
Latin America
1
Discrimination & Stigma
1
Child Health / Pediatrics
1
Attention deficit hyperactivity disorder (ADHD)
1
Mental Health Guidelines
1
Epilepsy
1
International
1
Situation Reports & Updates
1
Prevention & Preparedness
1
Research & Development
1
COVID-19
1
Public Health
1
Poster & Infographics
1
Video & Audio
1
Diagnostics & Laboratory Guidance
1
Surveillance & Contact tracing
1
Dashboards & Maps
1
Human Rights
1
For Older People
1
Resource Platforms others
1
Country-specific Platforms
1
HIV and COVID-19
1
At Home
1
Gambling
1
Non-pharmaceutical interventions (NPIs)
1
Long-term Care Facilities
1
Johnson & Johnson
1
Sputnik V
1
Hygiene
1
Sanitation
1
Extreme Situations
1
Nurses
1
Chile
1
Falsified & Substandard
1
HIV &TB
1
Epilepsy
1
Reports & Studies
1
Zoonoses
1
WASH Water Sanitation & Hygiene
1
MPOX - Monkeypox
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Onchocerciasis
1
General Information
1
Global Overview
1
General
1
War Surgery & Wound Care
1
Policies and guidelines
1
others
1
Clinical Guidelines
1
Bipolar Affective Disorders
1
Protection
1
Human Rights & the Right to Health
1
TB & Prisoners
1
Policy
1
Health Care Systems
1
Assessment
1
Clinical Guidelines
1
Antiretroviral Treatment ART
1
TB
1
Lobby and Advocacy
1
Eastern Europe & Central Asia
1
Laboratory & Diagnostics
1
Neurological disorders, Others
1
Global Health Ethics
1
Communication & Training
1
Preparedness & Prevention
1
Stand 1.12.2020
Vaccines
recommended
COVID Reference 23 May 2021
Vacunas
recommended
COVID Reference 23 May 2021
Existen notificaciones de eventos relacionados con la vacuna (ESAVI) de
miocarditis/pericarditis en adolescentes tras la administración de vacunas ARNm(Pfizer y Moderna) especialmente tras la segunda dosis. Al momento no seencuentra asociación entre la enfermedad y la administración de la vacuna...
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Stand 21. Dezember 2021
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Seit August 2021 empfiehlt die Ständige Impfkommission (STIKO) allen Kindern und Jugendlichen ab 12 Jahren die Corona-Schutzimpfung mit Comirnaty® von BioNTech/Pfizer. Seit Mitte Dezember können auch Kinder zwischen 5 und 11 Jahren mit dem darauf angepassten Impfstoff von BioNTech/Pfizer geimpft ...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc...
(Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та Spikevax® виробництва Moderna);
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. ...
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. 30 μg von BioNTech/Pfizer...
ІНФОРМАЦІЙНИЙ ЛИСТ Для вакцинації проти COVID-19 (коронавірусне захворювання 2019 р.) (Первинна вакцинація)
recommended
– з вакциною на білковій основі
(Nuvaxovid® виробництва Novavax)
Станом на: 15 лютого 2022 р. (даний інформаційний лист постійно оновлюється)
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Cor...
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key information about COVID-19 vaccines through short instructional videos, vaccine explainers, job aids, topic br...
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos prioritarios de vacunación están definidos según el Plan...
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de...
Countries, partners, and donors are committed to
the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more
than funding; it requires health personnel with the
right mix of skills, and well supported and managed
health systems. Mass drug administra...
In 2018, we are celebrating 20 years of progress in eliminating trachoma, the world’s leading infectious cause of blindness. Set up in 1998 by Pfizer Inc. and the Edna McConnell Clark Foundation, the International Trachoma Initiative (ITI) supports Ministries of Health in over 30 countries around ...
